Case Report: Primary lymphoepithelioma-like intrahepatic cholangiocarcinoma.
EBV – epstein-barr virus
LEL-ICC
lesion
liver
surgical resection
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2023
2023
Historique:
received:
18
01
2023
accepted:
19
04
2023
medline:
18
5
2023
pubmed:
18
5
2023
entrez:
17
5
2023
Statut:
epublish
Résumé
Lymphoepithelioma-like intrahepatic cholangiocarcinoma (LEL-ICC) is a rare variant of intrahepatic cholangiocarcinoma. Epstein-Barr virus (EBV) infection was considered to play a pivotal role in the tumorigenesis of LEL-ICC. It is difficult to diagnosis of LEL-ICC due to the lack of specific features regarding the laboratory test results and imaging findings. At present, the diagnosis of LEL-ICC mainly depends on the histopathologic and immunohistochemical examinations. In addition, the prognosis of LEL-ICC was better than classical cholangiocarcinomas. To our knowledge, only few cases of LEL-ICC have been reported in the literature. We presented a case of a 32-year-old Chinese female with LEL-ICC. She had a 6-month history of upper abdominal pain. The magnetic resonance imaging (MRI) showed a 1.1× 1.3 cm lesion in the left lobe of liver, appearing low signal intensity on T1-weighted images and high signal intensity on T2-weighted images. The patient underwent laparoscopic left lateral sectionectomy. The postoperative histopathologic and immunohistochemical examinations results allowed for the definitive diagnosis of LEL-ICC. The patient was free from tumor recurrence after a 28 months follow-up. In this study, we reported a rare case of LEL-ICC associated with both HBV and EBV infection. EBV infection might play a pivotal role in the carcinogenesis of LEL-ICC, and surgical resection is still the most effective treatment at present. Further research on the etiology and treatment strategies of LEL-ICC is required.
Sections du résumé
Background
UNASSIGNED
Lymphoepithelioma-like intrahepatic cholangiocarcinoma (LEL-ICC) is a rare variant of intrahepatic cholangiocarcinoma. Epstein-Barr virus (EBV) infection was considered to play a pivotal role in the tumorigenesis of LEL-ICC. It is difficult to diagnosis of LEL-ICC due to the lack of specific features regarding the laboratory test results and imaging findings. At present, the diagnosis of LEL-ICC mainly depends on the histopathologic and immunohistochemical examinations. In addition, the prognosis of LEL-ICC was better than classical cholangiocarcinomas. To our knowledge, only few cases of LEL-ICC have been reported in the literature.
Case presentation
UNASSIGNED
We presented a case of a 32-year-old Chinese female with LEL-ICC. She had a 6-month history of upper abdominal pain. The magnetic resonance imaging (MRI) showed a 1.1× 1.3 cm lesion in the left lobe of liver, appearing low signal intensity on T1-weighted images and high signal intensity on T2-weighted images. The patient underwent laparoscopic left lateral sectionectomy. The postoperative histopathologic and immunohistochemical examinations results allowed for the definitive diagnosis of LEL-ICC. The patient was free from tumor recurrence after a 28 months follow-up.
Conclusion
UNASSIGNED
In this study, we reported a rare case of LEL-ICC associated with both HBV and EBV infection. EBV infection might play a pivotal role in the carcinogenesis of LEL-ICC, and surgical resection is still the most effective treatment at present. Further research on the etiology and treatment strategies of LEL-ICC is required.
Identifiants
pubmed: 37197425
doi: 10.3389/fonc.2023.1146933
pmc: PMC10183565
doi:
Types de publication
Case Reports
Langues
eng
Pagination
1146933Informations de copyright
Copyright © 2023 Liu, Xu, Regmi, Li and Lin.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Clin Gastroenterol Hepatol. 2018 Aug;16(8):e87
pubmed: 29574027
Int J Clin Exp Pathol. 2014 Oct 15;7(11):7951-6
pubmed: 25550837
Laryngoscope. 1982 May;92(5):510-4
pubmed: 7078327
BMC Urol. 2017 Apr 27;17(1):34
pubmed: 28449665
Am J Pathol. 2017 Jul;187(7):1438-1444
pubmed: 28500863
Case Rep Oncol. 2011 Feb 14;4(1):68-73
pubmed: 21475593
Ann Transl Med. 2019 Sep;7(18):497
pubmed: 31700933
Int J Surg Pathol. 2011 Aug;19(4):514-7
pubmed: 20444729
Hum Pathol. 1996 Aug;27(8):848-50
pubmed: 8760021
World J Gastroenterol. 2015 Mar 28;21(12):3472-9
pubmed: 25834311
Histopathology. 2014 Nov;65(5):674-83
pubmed: 24804938
J Thorac Oncol. 2018 Feb;13(2):218-227
pubmed: 29191777
Pathol Int. 2008 Jan;58(1):69-74
pubmed: 18067645